BioElectron Update - Guy Miller & Matthew Klein - 6/23/2017

July 03, 2020 00:58:26
BioElectron Update - Guy Miller & Matthew Klein - 6/23/2017
MitoAction Expert Series
BioElectron Update - Guy Miller & Matthew Klein - 6/23/2017

Jul 03 2020 | 00:58:26

/

Show Notes

uy Miller, BioElectron’s CEO, and Matthew Klein, its Chief Medical Officer, will discuss the following:

About The Speaker:

Guy Miller, MD, PhD is Founder, Chairman, and Chief Executive Officer of BioElectron Technology Corporation. BioElectron is a technology company focused on biological energy. Dr. Miller holds a PhD in chemistry and an MD, with subspecialty training in critical care medicine. He completed his surgical internship at University of Chicago, and completed his residency and fellowship training at Johns Hopkins, where he was an assistant professor. His research has been funded by numerous organizations including DARPA. He is an attending physician in medical surgical critical care at Stanford University Medical Center/VAPAHCS.

Matthew B. Klein, MD, MS, FACS is Chief Medical Officer of BioElectro Technology Corporation. He received his MD degree from Yale University and completed his surgical training at Stanford University. He also holds a Master’s degree in Epidemiology. Dr. Klein most recently held the David and Nancy Auth-Washington Research Foundation Endowed Chair for Restorative Burn Surgery at the University of Washington where he was a professor of surgery and epidemiology. His clinical and research expertise spans several fields, including skin biology, wound healing, systemic inflammatory disorders, clinical trials, and nutrition. Dr. Klein has authored or co-authored over 80 peer-reviewed manuscripts and 15 book chapters related to these areas, and sits on the editorial review boards of several prominent biomedical journals. He is currently a clinical associate professor at Stanford University.

For accompanying slides, click here.

Other Episodes

Episode

June 23, 2022 01:10:04
Episode Cover

Interpreting Common Lab Tests for Mitochondrial Disease

Dr. Mark Korson from Tufts Floating Hospital for Children gives a "crash course" in interpreting lab values! Most patients with mitochondrial disease have faced...

Listen

Episode 0

June 08, 2020 00:42:32
Episode Cover

Understanding the New Recommendations on the Safety of Drug Use in Patients with a Primary Mitochondrial Disease - Dr. Amel Karaa - 2/28/20

“Understanding the New Recommendations on the Safety of Drug Use in Patients with a Primary Mitochondrial Disease” Clinical guidance is often sought when prescribing...

Listen

Episode

May 19, 2022 01:03:14
Episode Cover

Introducing Bendavia

Join us with Dr. Ben Bronstein and Travis Wilson from Stealth Peptides. Stealth Peptides is a private biotech company responsible for the development of...

Listen